このページの先頭ですサイトメニューここから
このページの本文へ移動
豊川市 きらっと☆とよかわっ!
  • 音声読み上げ・文字拡大
  • モバイルサイト
  • English
  • Portugues
  • Espanol
  • 中文
  • Tiếng Việt
  • サイトマップ
  • くらし・手続き
  • 子育て・学校
  • 催事・文化
  • 公共施設
  • 市政情報
  • きらっと☆とよかわっ!
サイトメニューここまで


本文ここから

What is Novel Corona Vaccine? 「新型コロナワクチンとは?」

更新日:2021年7月29日

What is Novel Corona Vaccine?

Outline of vaccination against COVID-19

Vaccination against COVID-19 is implemented by the country and municipalities as a part of vaccination project against Novel Corona Virus (SARS-CoV-2). Vaccination is eligible for public expense and persons wishing for vaccination can take it for free. Eligibility for the vaccine manufactured by Pfizer is person aged over 12 years, and that for the vaccine manufactured by Takeda / Moderna is person aged over 18 years.

About the vaccine manufactured by Pfizer (June, 2021)

Effects of the vaccine and administration method

Effectiveness of vaccination is prevention of onset of COVID-19. Lower rate of onset of COVID-19 has been seen among persons who took vaccination than persons who did not take it (It is reported that preventive effectiveness is about 95 %.).

Item Content
Sales name Comirnaty intramuscular injection
Efficiency / Effects Prevention of infectious diseasae caused by SARS-CoV-2
Vaccination frequency / Interval 2 times (usually 3 weeks apart) ※Intramuscular injection

Inoculation target

Person aged over 12 years (Efficacy and safety for persons aged under 12 years is not yet clear.)
Inoculation amount 0.5 mL per dose, total of 2 doses
  • After the 1st vaccination, the 2nd vaccination is normally to be taken with 3 week interval (If the interval of the 1st time and 2nd time vaccination is over 3 weeks, take the 2nd vaccination as soon as possible.
  • If you take this vaccine on the 1st vaccination, make sure to take the same vaccine for the 2nd time.
  • It is believed that sufficient immunity is not achieved until about 7 days after the second dose of this vaccine has been administrated. Its preventive effectiveness has not been clarified at this point. Regardless of the vaccination, appropriate preventive measures against infection are necessary.

Person who cannot take vaccination

Person who meets the follwoing points cannot take vaccination. If meeting any of them, make sure to mention it to the doctor during the pre-vaccination consultation.

  • Person who obviously has fever (※1)
  • Person who has severe acute disease
  • Person who has medical history of severe hypersensitivity (※2) to the vaccine's ingredients
  • Person who is not in appropriate condition to take vaccination other than afore-mentioned points

(※1) To have obviously fever usually means to have body temperature over 37.5 °C. However, the definition is not always the case when the person's body temperature is below 37.5 °C which is considered to be high in comparison to the person's normal body temperature.
(※2) Meaning anaphylaxis and multiple symptoms which have probability of anaphylactic conditions such as generalized skin / mucous membrane symptoms, stridor (Wheezing), breathing difficulty, tachycardia (Frequent pulse) and hypotension (blood pressure decrease).

Person who needs to be careful with vaccination

Person who meets the following points need to be careful with vaccination. If meeting any of them, make sure to mention it to the doctor during the pre-vaccination consultation.

  • Person who receives anticoagulant therapy, person who has thrombocytopenia (Platelets decrease) or coagulation disorders
  • Person who has been diagnosed with immunodefficiency in the past, person who has close relatives with congenital immunodeficiency
  • Person who has underlying disease such as heart, kidney, liver, blood disorders, or developmental disorders
  • person who had allergic symptoms such as fever and generalized rash within 2 days after vaccination in the past
  • Person who had convulsions in the past
  • Person who may be allergic to the ingredients of this vaccine

For person who is pregnant, has possibility of being pregnant and person who is breastfeeding, make sure to mention it to the doctor during pre-vaccination consultation. This product contains an additive that has never been used in a vaccine before. For person who had hypersensitivity and allergies with medicine in the past, please mention it to the doctor during pre-vaccination consultation.

Precautions after vaccination

  • After taking vaccination, you are requested to stay at the vaccination venue for more than 15 minutes (For person with severe allergic history including anaphylastic shock, feeling bad or becoming unconscious in the past, should stay over 30 minutes.). If you notice any negative physical condition, tell the doctor immediately (Medical staff can cope with sudden side reactions.).
  • Please keep the injected part clean. Taking a bath on the day is all right but do not rub the injected part.
  • Leading normal daily life is OK, but refrain from doing hard exercise and drinking excessive alcohol for rest of the day.

Side reactions

Major side reactions are pain in the injected part, headache, joint / muscular pain, fatigue, feeling chilly, and fever etc. As severe side reactions which might occur with a very low probability, there are shock and anaphylaxis. In addition, this is a new kind of vaccine which may have possiblity of appearance of unknown symptoms. If you notice any concerning symptoms, consult the doctor of vaccidnation or your family doctor.

Relief System for Injury to Health with Vaccination

Vaccination may cause injury to health (Becoming sick or disabled). Quite rare, but it is not to be eliminated and a relief system is available for the matter. In case of injury to health caused by vaccination against COVID-19, relief (Benefit for medical expense, disability pension etc.) is available based on Immunization Act. About necessary procedures for application, contact Novel Corona Vaccine Call Center (0533-56-2210).

Characteristics of the COVID-19 vaccine manufactured by Pfizer

This drug is a messenger RNA (mRNA) vaccine, and it is a formulation in which the mRNA, which is the blueprint for the spike protein of SARS-CoV-2 (a protein necessary for the virus to enter human cells), is encased in a lipid membrane. When mRNA is taken into human cells through inoculation with this drug, viral spike proteins are produced in the cells based on the mRNA, and neutralizing antibodies against the spike proteins and cellular immune responses are induced, which is thought to prevent infections caused by SARS-CoV-2.
The drug contains the following ingredients.

Item Content
Active Ingredient
  • Trazinameran (mRNA encoding the full-length spike protein that binds to the human cell membrane)
Addtives
  • AlC-0315: [(4-hydroxybutyl) azanediyl] bis (hexane-6, 1-diyl) bis (2-hexyldecanoate)
  • ALC-0159: 2- [(polyethylene glycol) -2000] -N, N- ditetradecylacetamide
  • DSPC: 1,2- distearoyl-sn-glycero-3-phosphocholine
  • Cholesterol
  • Potassium chloride
  • Monobasic potassium phosphate
  • Sodium chloride
  • Dibasic sodium phosphate dihydrate
  • Sucrose

About the vaccine manufactured by Takeda / Moderna (June, 2021)

Effectiveness and method of vaccination

This vaccine prevents the onset of COVID-19. It has been found that fewer people have developed COVID-19 among those who have received the vaccine than those who have not received it. (The effectiveness in preventing the onset of disease has been reported to be approximately 94 %.).

Item Content
Sales name Moderna COVID-19 vaccine intramuscular injection
Efficiency / Effects Prevention of infectious disease caused by SARS-CoV-2
Vaccination frequency / Interval 2 times (Usually 4 weeks apart) ※Intramuscular injection
Inoculation target Person aged over 18 years (Efficacy and safety for people under 18 years of age is not yet clear.)
Inoculation amount 0.5 mL per dose, total of 2 doses

  • After the 1st vaccination, the 2nd vaccination is normally to be taken with 4 week interval (If the interval of the 1st time and 2nd time vaccination is over 4 weeks, take the 2nd vaccination as soon as possible.
  • If you take this vaccine on the 1st vaccination, make sure to take the same vaccine for the 2nd time.
  • Clinical trials have confirmed that sufficient immunity is not achieved until about 14 days after the second dose of this vaccine has been administrated. Its preventive effectiveness has not been clarified at this point. Regardless of the vaccination, appropriate preventive measures against infection are necessary.

Person who cannot take vaccination

Person who meets the following points cannot take vaccination. If meeting any of them, make sure to mention it to the doctor during pre-vaccination consultation.

  • Person who obviously has fever (※1)
  • Person who has severe acute disease
  • Person who has medical history of severe hypersensitivity (※2) to the vaccine's ingredients
  • Person who is not in appropriate condition to take vaccination other than afore-mentioned points

(※1) To have obviously fever usually means to have body temperature over 37.5 °C. However, the definition is not always the case when the person's body temperature is below 37.5 °C which is considered to be high in comparison to the person's normal body temperature.
(※2) Meaning anaphylaxis and multiple symptoms which have probability of anaphylactic conditions such as generalized skin / mucous membrane symptoms, stridor (Wheezing), breathing difficulty, tachycardia (Frequent pulse) and hypotension (blood pressure decrease).

Person who needs to be careful with vaccination

Person who meets the following points need to be careful with vaccination. If meeting any of them, make sure to mention it to the doctor during pre-vaccination consultation.

  • Person who reveives anticoagulant therapy, person who has thrombocytopenia (Platelets decrease) or coagulation disorders
  • Person who has been diagnosed with immunodeficiency in the past, person who has relatives with congenital immunodeficiency
  • Person who has underlying disease such as heart, kidney, liver, blood disorders, or developmental disorders
  • person who had allergic symptoms such as fever and generalized rash within 2 days after vaccination in the past
  • Person who had convulsions in the past
  • Person who may be allergic to the ingredients of this vaccine

For person who is pregnant, has possibility of being pregnant and person who is breastfeeding, make sure to mention it to the doctor during pre-vaccination cousultation. This product contains an additive that has never been used in a vaccine before. For person who had hypersensitivity and allergies with medicine in the past, please mention it to the doctor during pre-vaccination consultation.

Precautions after vaccination

  • After taking vaccination, you are requested to stay at the vaccination venue for more than 15 minutes (For person with severe allergic history including anaphylactic shock, feeling bad or becoming unconscious in the past, should stay over 30 minutes.). If you notice any negative physical condition, tell the doctor immediately (Medical staff can cope with sudden side reactions.).
  • Please keep the injected part clean. Taking a bath on the day is all right but do not rub the injected part.
  • Leading normal daily life is OK, but refrain from doing hard exercise and drinking excessive alcohol for rest of the day.

Side reactions

Major side reactions are pain in the injected part (※), headache, joint / muscular pain, fatigue, feeling chilly, and fever etc. As severe side reactions which might occur with a very low probability, there are shock and anaphylaxis. In addition, this is a new kind of vaccine which may have possiblity of appearance of unknown symptoms. If you notice any concerning symptoms, consult the doctor of vaccidnation or your family doctor.
(※) There are more cases of feeling pain on the following day than right after vaccination. Pain and swelling might also occur about 1 week after vaccination.

Relieaf System for Injury to Health with Vaccination

Vaccination may cause injury to health (Becoming sick or disabled). Quite rare, but it is not to be eliminated and a relief system is available for the matter. In case of injury to health caused by vaccination against COVID-19, relief (Benefit for medical expense, disability pension etc.) is available based on Immunization Act. About necessary procedures for application, contact Novel Corona Vaccine Call Center (0533-56-2210).

Characteristics of Novel Corona Vaccine manufacutured by Takeda / Moderna

This drug is a messenger RNA (mRNA) vaccine. In this formulation, the mRNA, which is the blueprint for the spike protein of SARS-CoV-2 (a protein necessary for the virus to enter human cells), is encased in a lipid membrane. When mRNA is taken into human cells through inoculation with this drug, viral spike proteins are produced in the cells based on the mRNA, and neutralizing antibodies against the spike proteins and cellular immune responses are induced, which is thought to prevent infections caused by SARS-CoV-2.

The drug contains the following ingredients.

Item Content
Active Ingredient
  • CX-024414 (mRNA encoding the full-length spike protein that binds to the human cell membrane)
Additives
  • SM-102: heptadecane-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy) hexyl) amino) octanoate)
  • Cholesterol
  • DSPC: 1,2-Distearoyl-sn-glycero-3-phosphocholine
  • 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (PEG 2000-DMG)
  • Trometamol
  • Trometamol hydrochloride
  • Glacial acetic acid
  • Sodium acetate hydrate
  • Sucrose

Prevention of discrimination etc. to persons who do not wish to take vaccination

Do not force others to take vaccination nor give them discriminative treatment.

Although vaccination against COVID-19 is recommended to take, it is not obligatory. Vaccination is conducted only when the person gives consent to it after sufficient information is given.

Those who take vaccination are asked to understand both effectiveness and risk of side reactions of the vaccine, and take vaccination with one's own will. Vaccination is not conducted without consent of the person.
Please be cosiderate not to force coworkers and people around you to take vaccination, and not to give discriminative treatment to persons who have not taken vaccination.
Consultation booth for bullying and harassment etc. at work (In Japanese only)
Consultation booth for human rights
Every one of us is expected to be considerate of others and behave calmly.

Be careful with fraud taking advantage of Novel Corona Vaccine.

Be careful with persons " Pretending to be" personnel of the Civil Service.

Consultations have been required at Consumer Center about phone calls which try to steal money and personal information by insisting the necessity for vaccination against COVID-19. Neither money nor personal information is demanded by phone / e-mail. If you have concerns, do not worry by yourself. Respond to that sort of approach calmy based on accurate information, and ask for consultations.

The latest infromation from Central Government is here (External Link).

PDF形式のファイルを開くには、Adobe Acrobat Reader DC(旧Adobe Reader)が必要です。
お持ちでない方は、Adobe社から無償でダウンロードできます。
Get Adobe Acrobat Reader DCAdobe Acrobat Reader DCのダウンロードへ

CONTACT

City of Toyokawa - International and Civic Activity Division
豊川市役所 市民協働国際課
Postal code: 442-8601
Address: 1-1, Suwa, Toyokawa, Aichi, Japan
Phone: 0533-89-2158
Open days and time: Monday - Friday, 8:30am - 5:15pm
Holidays: Saturday, Sunday, National and Year-end and New-year Holidays December 29 - January 3

本文ここまで

サブナビゲーションここから

Information concerning COVID-19 新型コロナウイルス感染症に関するお知らせ

サブナビゲーションここまで

以下フッターです。

豊川市役所

〒442-8601 愛知県豊川市諏訪1丁目1番地 電話:0533-89-2111(代表)
開庁日時:月曜から金曜 午前8時30分から午後5時15分 閉庁日:土曜・日曜、国民の祝日、年末年始(12月29日から1月3日)
法人番号:1000020232076(法人番号について
Copyright © Toyokawa City. All Right Reserved.
フッターここまでこのページの上へ戻る